{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-18T17:18:32.991266+00:00","company":{"ticker":"PKTX","cik":1128189,"company_name":"ProtoKinetix, Inc."},"pagination":{"limit":100,"returned":5,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{},"facts":[{"fact_type":"executive_change","fact_key":"ba623d73cb","cik":1128189,"ticker":"PKTX","company_name":"ProtoKinetix, Inc.","filed_at":"2026-06-17T21:28:41+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-06-17","interim":false,"role":"President","role_category":"president","successor_name":null,"successor_named":false},"claim":"Keith Brunt was appointed as President at ProtoKinetix, Inc..","evidence_excerpt":"On June 17, 2026, Keith Brunt, a Translational Scientist and Associate Professor of Pharmacology, in the Faculty of Medicine at Dalhousie Medicine in New Brunswick, was appointed as a director and as the president of the Company, to hold such office until his successors are duly elected and qualified.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001079973-26-000855","anchor_url":"https://secwatch.observer/filing/0001079973-26-000855#claim-ba623d73cb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1128189/000107997326000855/0001079973-26-000855-index.htm"},{"fact_type":"executive_change","fact_key":"831df1739b","cik":1128189,"ticker":"PKTX","company_name":"ProtoKinetix, Inc.","filed_at":"2026-06-17T21:28:41+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-06-17","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Keith Brunt was appointed as Director at ProtoKinetix, Inc..","evidence_excerpt":"On June 17, 2026, Keith Brunt, a Translational Scientist and Associate Professor of Pharmacology, in the Faculty of Medicine at Dalhousie Medicine in New Brunswick, was appointed as a director and as the president of the Company, to hold such office until his successors are duly elected and qualified.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001079973-26-000855","anchor_url":"https://secwatch.observer/filing/0001079973-26-000855#claim-831df1739b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1128189/000107997326000855/0001079973-26-000855-index.htm"},{"fact_type":"executive_change","fact_key":"cc33cceb32","cik":1128189,"ticker":"PKTX","company_name":"ProtoKinetix, Inc.","filed_at":"2026-06-17T21:28:41+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-06-17","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Jason Lamp was appointed as Director at ProtoKinetix, Inc..","evidence_excerpt":"On June 17, 2026, Michael Jones, of Corbin, Kentucky, and Jason Lamp, of Roswell, Georgia were appointed as directors of the Company to serve as members of the Board, and to hold such office until their successors are duly elected and qualified.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001079973-26-000855","anchor_url":"https://secwatch.observer/filing/0001079973-26-000855#claim-cc33cceb32","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1128189/000107997326000855/0001079973-26-000855-index.htm"},{"fact_type":"executive_change","fact_key":"bd8e4fd944","cik":1128189,"ticker":"PKTX","company_name":"ProtoKinetix, Inc.","filed_at":"2026-06-17T21:28:41+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2026-06-17","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Michael Jones was appointed as Director at ProtoKinetix, Inc..","evidence_excerpt":"On June 17, 2026, Michael Jones, of Corbin, Kentucky, and Jason Lamp, of Roswell, Georgia were appointed as directors of the Company to serve as members of the Board, and to hold such office until their successors are duly elected and qualified.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001079973-26-000855","anchor_url":"https://secwatch.observer/filing/0001079973-26-000855#claim-bd8e4fd944","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1128189/000107997326000855/0001079973-26-000855-index.htm"},{"fact_type":"executive_change","fact_key":"33ef12620e","cik":1128189,"ticker":"PKTX","company_name":"ProtoKinetix, Inc.","filed_at":"2026-06-17T21:28:41+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2026-03-31","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Edward McDonough resigned as Director at ProtoKinetix, Inc..","evidence_excerpt":"On March 31, 2026, Mr. Edward McDonough, after serving many years as a trusted advisor to ProtoKinetix, Incorporated (the “Company”) under the leadership of Clarence E. Smith, notified the Board of Directors of the Company (the “Board”) of his resignation from the Board effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001079973-26-000855","anchor_url":"https://secwatch.observer/filing/0001079973-26-000855#claim-33ef12620e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1128189/000107997326000855/0001079973-26-000855-index.htm"}]}